Www.gavi.org Gavi’s Measles and Rubella Programme:Update Stefano Malvolti September 2015, Washington DC Page: 1 Reach every child.

Slides:



Advertisements
Similar presentations
Global Measles and Rubella Strategic Plan
Advertisements

TT TT Procured by UNICEF TT historical demand and forecast overview Upcoming Tender Period.
Measles elimination in the African Region- Regional updates
Measles Outbreaks in Southern Africa in 2010 Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
World Health Organization
Global Immunization Performance Update through 2011.
1 AFRO Measles TAG – Nairobi 2-3 June 2015 MCV2 Introduction and the Second Year of Life Contact Lessons and way forward Raoul KAMADJEU UNICEF ESARO Meeting.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
1 Progress Towards Global and Regional Immunization Goals Workshop on Prevention and Control of Vaccine Preventable Disease in Displaced Person Temporary.
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
Americas Bolivia (2008) Guyana (2010) Haiti (2013) Honduras (2009) Nicaragua (2006) Europe Armenia (2012) Georgia (2013) Moldova (2012) Middle East Tajikistan.
Regional measles elimination program updates B Masresha WHO AFRO AFR MR TAG Meeting Nairobi, June 2015.
AFR MR TAG Global Measles and Rubella Update 5 th African Regional Measles/Rubella TAG Meeting 2 nd -3 rd June 2015.
The changing vaccination landscape and the sources of vaccination data
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
MR introduction and rubella epidemiology in AFRO Regional MR TAG Nairobi, Kenya June 2-3, 2015.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Road Map to Achieving Goals 11 th Annual Meeting Measles and Rubella Initiative Washington, DC Peter Strebel, WHO/EPI.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
12 th Annual Meeting The Measles & Rubella Initiative Western Pacific Regional Update: The Final Push September 2013 American Red Cross National.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
BASIC FACTS ABOUT GAVI, THE VACCINE ALLIANCE Page: 1 #vaccineswork Gavi/2012/Doune Porter.
World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Measles Elimination in the Western Pacific Region 2007 Partners.
Accelerating Progress towards Measles and Rubella Elimination WHO Western Pacific Region UNICEF East Asia and Pacific Region 1 21 June 2016 Geneva, Switzerland.
GAVI’S NEW MEASLES AND RUBELLA STRATEGY Dr. Khin Devi Aung Gavi Secretariat 21 June 2016, Geneva 1 #vaccineswork.
UN-REDD Partner Countries “at a glance” Updated January 2012.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
Measles Rubella Meeting
World Health Organization
Session 4 Cross Cutting MR and RI Priorities Introduction
Opportunities in the Second Year of Life (2YL)
12th Annual Meeting of the Measles and Rubella Initiative
Global Overview of Measles
WHO AFRO Technical Coordinator for Health Emergencies
World Health Organization
Measles Containing Vaccines
Gavi’s Measles and Rubella Programme
September 2018.
Progress and Challenges with achieving Universal Immunization Coverage
World Health Organization
Session 1: New Opportunities and New Direction
African Region- priorities to reach the 2020 measles elimination goal.
Reported measles cases, measles coverage for 1st and 2nd doses and supplementary measles activities for the African Continent For 1990 – 2007 Data as of.
January 2019 Note: EURO data has not been updated in this monthly update, and data submitted by EURO on December 7, 2018 is being used here.
March 2019 Please note that all data contained within is provisional. The number of cases of measles and rubella officially reported by a member state.
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
June 2019 Please note that all data contained within is provisional. The number of cases of measles and rubella officially reported by a member state.
July 2019 Please note that all data contained within is provisional. The number of cases of measles and rubella officially reported by a member state.
2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)
World Health Organization
October 2019 Please note that all data contained within is provisional. The number of cases of measles and rubella officially reported by a member state.
Presentation transcript:

Gavi’s Measles and Rubella Programme:Update Stefano Malvolti September 2015, Washington DC Page: 1 Reach every child

MANY REGIONS AT RISK / OFF TRACK FROM MEASLES ELIMINATION GOALS Source: WHO Source: WHO/UNICEF coverage estimates 2014 revision. July Immunization Vaccines and Biologicals, (IVB), World Health Organization. RCV data is per July 2014 estimates, except for the year WHO Member States. Date of Slide: 16 September Gavi 73 numbers are Gavi Secretariat calculated. May revise upwards after reconciliation of data 85% 56% 46% 72% 22% 15% 78% 37% 59% 2%

GAVI 4.0: RENEWED FOCUS ON MEASLES Gavi strategy targets to be approved by Board in December Reach of routine coverage 3rd dose of pentavalent vaccine First dose of routine measles vaccine Breadth of protection Average coverage across all Gavi supported vaccines Equity of coverage Difference in penta3 coverage based on: Geography (by district) Wealth Education status of mother / female caregiver Gavi strategy indicators Source: Gavi; GVAP

EXISTING GAVI MEASLES-RUBELLA PROGRAM Past: Gavi-IFFIm provided US$ 176M to M&RI in Current: Direct: Indirect support: HSS Performance-based funding with measles coverage indicator Gavi has disbursed US$550 million by end US$ 700 million more forecasted by 2020

MEASLES AND RUBELLA PROGRAMMES REACHED 24 COUNTRIES BY END 2014 CountryYear Viet Nam DPR of Korea Ghana2012 (Feb) Cambodia2012 (Jun) Eritrea2012 (Jun) Gambia2012 (Aug) Bangladesh2012 (Sep) Myanmar2012 (Nov) Burundi2013 (Jan) Zambia2013 (Jul) Sao Tome and Principe2013 (Dec) Tanzania2014 (May) Senegal2014 (Aug) Burkina Faso2014 (Oct) Measles Second Dose (14 countries) Measles-Rubella campaigns (13 countries) Measles SIAs (5 countries) CountriesYear Ethiopia2013 (May-Jun) Nigeria2013 (Oct, Nov) DRC*2013 Aug, 2014 July Pakistan*2014 (May) Chad*2014 (Jun, Oct) * In phases Myanmar in Jan 2015, PNG in August 2015

MOST OF GAVI COUNTRIES FORECASTED TO INTRODUCE MR < >2020 Total MR MSD MSIA516 MR forecast latest as of 16 Sep MSD forecast from SDFv11 MSIA countries with more than 1 campaign counted once Number of country introductions

,GAVI PROGRAMS REACHED IN EXCESS OF 650M CHILDREN AND ADOLESCENTS Program start – Program start – 2020 MR170M480M650M MSD64M236M300M MSIA149M3M*151M* *Does not include DRC and Ethiopia measles SIA in 2016, and does not include numbers vaccinated through US$176m grant to MRI before 2010 Forecasted number of children and adolescents vaccinated

GAVI’S LOOKING AT DEFINING A MEASLES AND RUBELLA STRATEGY Aim: Determine what Gavi should support to get the best pragmatic return on investment Technical Working Group addressed the following questions: What makes sense for Gavi to support? Ideal pre-requisites for MR introduction Measles Second Dose Rationale Surveillance Steering Committee highlighted the following key principles:

SPECIFIC GOALS DEFINED FOR THE DEFINTION OF THE STRATEGY Simplicity and clarity of Gavi support Alignment with key principles of support applied to Gavi vaccines (support till graduation and co-financing) Recognition of the specific role of SIA in measles control Self-financing of the first dose of measles vaccine in national immunization programme Definition of a long term plan for measles and rubella activities based on solid modelling of the diseases 9 #add your hashtag

Measles Cases, Routine MCV1 Coverage, and National Measles SIAs, Zambia, 1999 – Courtesy of WHO (JM Okwo Bele)

THANK YOU Page: 11 Reach every child